Boston Partners’s Apollo Endosurgery, Inc. APEN Stock Holding History

Boston Partners’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32,403	Closed	-$321K	–	755
2023 Q1	$321K	Sell	32,403 -103,920	-76%	-$1.03M	﹤0.01%	646
2022 Q4	$1.36M	Sell	136,323 -32,210	-19%	-$240K	﹤0.01%	483
2022 Q3	$929K	Buy	+168,533	New	+$935K	﹤0.01%	526

Boston Partners's APEN Position: Q2 2023 in Review

Boston Partners sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 32,403 shares — an estimated $321K sold.

Boston Partners first reported a position in APEN in Q3 2022 and held it in 3 quarters. The position peaked at $1.36M in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Boston Partners reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Boston Partners sold 32,403 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $321K.
Boston Partners first reported a position in Apollo Endosurgery, Inc. in Q3 2022 and held it in 3 quarters.
Boston Partners's Apollo Endosurgery, Inc. position peaked at $1.36M in Q4 2022.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Boston Partners's 13F filing for Q2 2023, filed 10 Aug 2023.